Teva Pharma is trading at $41.25, up +5.10%, before the October 9, 2026 open; no clear same-day catalyst is confirmed.
- The October 8 close was $39.25, following several sessions of relatively small moves.
- Recent coverage about the end of Teva’s UK nursing-union partnership is unrelated to the rise; broader market indicators were mixed.
- No reliable activity or volume details were found.